comparemela.com

Latest Breaking News On - Pharmabcine inc - Page 3 : comparemela.com

PharmAbcine to Participate in the 41th Annual J.P. Morgan Healthcare Conference and Biotech Showcase™ 2023 during JPM Week

DAEJEON, South Korea, Dec. 8, 2022 /PRNewswire/ PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the developme.

Australia
Daejeon
Taejon-gwangyoksi
South-korea
San-francisco
California
United-states
Jin-san-yoo
Pharmabcine-inc
Ir-pr-team
Youtube
Linkedin

PharmAbcine to participate in Jefferies 2022 London Healthcare Conference

/PRNewswire/ PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics,.

Australia
Daejeon
Taejon-gwangyoksi
South-korea
London
City-of
United-kingdom
Jin-san-yoo
Pharmabcine-inc
Ir-pr-team
Youtube
Linkedin

PharmAbcine Announces Poster Presentations on Its anti-VISTA Antibody Candidate at SITC 2022

/PRNewswire/ PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today.

Boston
Massachusetts
United-states
Daejeon
Taejon-gwangyoksi
South-korea
Merck-keytruda
Pharmabcine-inc
Youtube
Linkedin
Prnewswire-pharmabcine-inc
Annual-meeting

PharmAbcine to Participate in BIO-Europe 2022

/PRNewswire/ PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next generation antibody therapeutics,.

Australia
Daejeon
Taejon-gwangyoksi
South-korea
Pharmabcine-inc
Ir-pr-team
Youtube
Linkedin
Prnewswire-pharmabcine-inc
Business-development-team
Vascular-endothelial-growth-factor-receptor

PharmAbcine to participate in Jefferies Global Healthcare Conference and BIO International Convention

DAEJEON, South Korea, May 11, 2022 /PRNewswire/ PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the developme.

Australia
New-york
United-states
San-diego
California
Daejeon
Taejon-gwangyoksi
South-korea
Australian
Jin-san-yoo
Human-research-ethics-committee-for-phase
Linkedin

vimarsana © 2020. All Rights Reserved.